Centaur Labs, a Boston, MA-based company which specializes in health data annotation, raised $16M+ in Series B funding.
The round was led by SignalFire, with participation from Matrix, Accel, Susa, Omega, Y Combinator and new investors Samsung Next and Alumni Ventures.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Centaur Labs helps health and science organizations accelerate AI development by using its network of over 50,000 experts to label multimodal data for model training, evaluation, monitoring, and feedback. Experts compete to be the best annotators on the company’s mobile app, DiagnosUs, ensuring skilled annotators contribute to the data. As a result, its delivers accuracy in annotations relative to in-house teams or outsourced generalists, all on a HIPAA-compliant platform.
In addition, Centaur Labs launched its on-demand AI data labeling product, which enables AI developers to collect labels from experts in less than one hour.
FinSMEs
10/10/2024